CN Patent

CN101027302B — 吡咯并吡啶激酶调节剂

Assigned to SGX Pharmaceuticals Inc · Expires 2011-05-11 · 15y expired

What this patent protects

本发明提供了新的吡咯并吡啶激酶调节剂以及使用该新的吡咯并吡啶激酶调节剂治疗由激酶活性介导的疾病的方法。

USPTO Abstract

本发明提供了新的吡咯并吡啶激酶调节剂以及使用该新的吡咯并吡啶激酶调节剂治疗由激酶活性介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101027302B
Jurisdiction
CN
Classification
—
Expires
2011-05-11
Drug substance claim
No
Drug product claim
No
Assignee
SGX Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.